is estimated at US$ 282.7 million in 2024 and is forecasted to increase to a value of US$ 733.3 million by 2034. Rising prevalence of communication disorders is primarily boosting the sales of speech ...
Speech generating devices (SGDs) may be funded using private health insurance, Medicare, and/or Medicaid. Medicaid is the provider of last resort, so funding must be sought through other funding ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results